Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -766,628 | -463,927 | -402,266 | -223,485 | -100,077 |
| Depreciation Amortization | 10,426 | -22,859 | -24,604 | 8,506 | 4,863 |
| Accounts payable and accrued liabilities | 19,906 | 34,584 | 11,225 | 2,896 | -12,470 |
| Other Working Capital | -3,452 | -54,895 | 81,320 | 12,737 | -37,005 |
| Other Operating Activity | 84,171 | 54,470 | 37,535 | 28,749 | 23,296 |
| Operating Cash Flow | $-655,577 | $-452,627 | $-296,790 | $-170,597 | $-121,393 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,211,499 | -3,086,701 | -1,329,896 | -102,745 | -336,341 |
| PPE Investments | -13,713 | -22,427 | -16,062 | -5,841 | -6,529 |
| Sale Of Investment | 1,705,826 | 1,200,194 | 624,462 | 183,171 | 130,562 |
| Other Investing Activity | -43,260 | -96,732 | -51,815 | 0 | 0 |
| Investing Cash Flow | $437,354 | $-2,005,666 | $-773,311 | $74,585 | $-212,308 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 2,435,656 | 636,043 | 856,480 | 3,900 |
| Other Financing Activity | 2,014 | 12,852 | 3,770 | 5,067 | 13,896 |
| Financing Cash Flow | $2,014 | $2,448,508 | $639,813 | $861,547 | $17,796 |
| Exchange Rate Effect | 2,439 | 426 | -6,686 | 137 | -439 |
| Beginning Cash Position | 389,195 | 398,554 | 835,528 | 69,856 | 386,200 |
| End Cash Position | 175,425 | 389,195 | 398,554 | 835,528 | 69,856 |
| Net Cash Flow | $-213,770 | $-9,359 | $-436,974 | $765,672 | $-316,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | -655,577 | -452,627 | -296,790 | -170,597 | -121,393 |
| Capital Expenditure | -13,713 | -22,427 | -16,062 | -5,841 | -6,555 |
| Free Cash Flow | -669,290 | -475,054 | -312,852 | -176,438 | -127,948 |